Cap-20 is a medication that contains Montelukast Sodium, a leukotriene receptor antagonist. It is primarily used to manage and prevent symptoms associated with asthma and allergic rhinitis (hay fever).
- Mechanism of Action: Montelukast works by blocking leukotrienes, which are chemicals in the immune system that contribute to inflammation, bronchoconstriction, and mucus production in the airways. By inhibiting these substances, Cap-20 helps to reduce inflammation, relax the airways, and improve breathing.
Indications:
- Asthma: Cap-20 is used as a preventive treatment for asthma in adults and children, helping to decrease the frequency of asthma attacks and improve overall lung function.
- Allergic Rhinitis: It is effective in alleviating symptoms such as sneezing, runny nose, and nasal congestion associated with seasonal and perennial allergies.
Dosage: The dosage of Cap-20 varies depending on the patient’s age and the condition being treated. It is typically taken once daily, and it is important to follow the prescribing physician’s instructions for optimal results.
Side Effects: Common side effects may include headache, abdominal pain, and fatigue. Most side effects are mild, but patients should report any unusual symptoms to their healthcare provider.
Note: Cap-20 is not intended for the immediate relief of asthma attacks and should be used as part of a comprehensive asthma management plan. Always consult a healthcare professional before starting or adjusting any medication.
Reviews
There are no reviews yet.